|[February 11, 2014]
Nestlé Skin Health Is Created Targeting Global Skin Health Needs
LAUSANNE, Switzerland --(Business Wire)--
Today, Nestlé S.A. (Nestlé) announced the creation of Nestlé Skin Health
S.A., a global leader focused on meeting the world's increasing skin
health needs with a scientifically-proven broad range of innovative
products. The company will be formed by the acquisition of 50% of
Galderma Pharma S.A. (Galderma), subject to regulatory clearance.
Galderma was established in 1981 as a dermatology-focused, Swiss-based
joint-venture between Nestlé and L'Oréal S.A. (L'Oréal) and had sales of
CHF € 2.0 billion in calendar year 2013.
Nestlé chairman Peter Brabeck-Letmathe said "Building on Nestlé's
historic strengths as a science based Nutrition, Health & Wellness
Company and through the recent creation of Nestlé Health Science S.A.,
the company has reinforced its strategic direction to offer nutritional
solutions from food & beverage to scientific products for a healthier
life. By creating Nestlé Skin Health S.A. and by leveraging Galderma's
current portfolio, formulations and innovative research, Nestlé will now
be able to provide science-based solutions for skin conditions. We
strive to have a portfolio of innovative products that meet the full
spectrum of people's skin health needs over the course of their lives
and to provide a holistic approach to people's health."
establishment of Nestlé Skin Health will allow the emergence of a global
leader that will leverage Galderma's and Nestlé's commercial operations
throughout the world. Galderma's Scientific Division, with laboratories
located in France, Sweden, United States, Japan and Switzerland, will
become part of Nestlé Skin Health and will actively collaborate with
Nestlé's global R&D network. Galderma's 33 commercial subsidiaries
around the world will continue to deliver scientifically-defined and
medically-proven products to patients and healthcare providers around
the world under the Galderma brand and organization.
Nestlé CEO Paul Bulcke said that "Nestlé Skin Health will have a broad
commercial and R&D platform able to deliver state of the art solutions
focused on maintaining, treating and restoring the health of the skin.
The new company will be particularly effective woking across different
trade channels to help people meet their skin health needs at a time
when access to medical care is getting more challenging due to resource
constraints." He added "Nestlé will contribute its Bübchen line of baby
care products to Nestlé Skin Health and provide Galderma access to
innovative technologies from Nestlé's R&D as well to help develop Nestlé
Skin Health's future portfolio."
Nestlé Skin Health will have a full range of products for the skin, hair
and nail including self-medication drugs, quasi-drugs such as medicated
soaps or sunscreens, therapeutic skin care products, nutraceuticals,
prescription drugs and medical devices. Nestlé Skin Health, a
wholly-owned subsidiary of Nestlé, will become operational as soon as
regulatory requirements and competition authority clearance have been
provided. Humberto C. Antunes, who currently serves as President and CEO
of Galderma, will lead Nestlé Skin Health reporting to the company's new
Board of Directors. Peter Brabeck-Letmathe will become Chairman and Paul
Bulcke Vice-chairman of the new Board of Directors of Nestlé Skin
Health, based in Switzerland.
On behalf of Galderma, Humberto C. Antunes, CEO explained "this is good
news for patients, consumers and healthcare providers, and the thousands
of Galderma employees throughout the world. As part of Nestlé Skin
Health, Galderma's medical heritage and portfolio can be expanded to
meet the full range of skin health needs, creating a new world leader
focused on improving people's lives."
The skin, the largest organ in the human body, plays an important role
in how we perceive ourselves and how others perceive us. Improving skin
health has a proven impact on well-being and quality of life and these
aspects, together with preventing, treating and curing medical
conditions related to the skin, are what Nestlé Skin Health aspires to
About Nestlé Skin Health
Responding to increasing consumer needs, Nestlé will extend its
activities to include the field of specialized, medical skin treatments
through the creation of Nestlé Skin Health S.A., a global leader focused
on meeting the world's increasing skin health needs with a
scientifically-proven broad range of innovative products. Nestlé Skin
Health S.A. will be managed as a wholly-owned subsidiary of Nestlé S.A.,
with its own Board of Directors, located in Lausanne, Switzerland. Upon
the approval and completion of Nestlé's acquisition of the 50% stake of
Galderma from L'Oréal, Galderma will form the foundation of Nestlé Skin
A global company exclusively dedicated to dermatology
is a global company founded in 1981 committed to delivering innovative
medical solutions to meet the dermatological needs of people throughout
their lifetime while serving healthcare professionals around the world.
The company has 33 wholly-owned affiliates with a worldwide network of
distributors and more than 5,000 employees. Galderma's extensive product
portfolio is available in 80 countries and treats a range of
dermatological conditions including: acne, rosacea, onychomycosis,
psoriasis & steroid-responsive dermatoses, pigmentary disorders, skin
cancer and medical solutions for skin senescence.
With approximately 19% of revenues invested each year to discover and
develop new products and access innovative technologies, the company is
one of the world's leading investors in dermatology R&D. Five
state-of-the-art R&D centers and five manufacturing sites are dedicated
to providing a wide range of innovative medical solutions which meet the
highest standards of safety and efficacy.
Strategic brands include Epiduo, Oracea, Clobex, Differin, Mirvaso,
Rozex/MetroGel, Silkis/Vectical, Tri-Luma, Loceryl, Cetaphil, Metvix,
Azzalure, Restylane and Emervel.
For more information, please visit Galderma's website www.galderma.com.
[ Back To TMCnet.com's Homepage ]